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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYWehere report that doxycycline, an antibacterial agent, exerts dramatic effects on human embryonic stem and induced pluripotent stem
cells (hESC/iPSCs) survival and self-renewal. The survival-promoting effect was also manifest in cultures of neural stem cells (NSCs)
derived from hESC/iPSCs. These doxycycline effects are not associated with its antibacterial action, but mediated by direct activation
of a PI3K-AKT intracellular signal. These findings indicate doxycycline as a useful supplement for stem cell cultures, facilitating their
growth and maintenance.INTRODUCTION
Human embryonic stem and induced pluripotent stem
cells (hESC/iPSCs) provide valuable platforms for develop-
mental biology, disease modeling, and regenerative medi-
cine (Ludwig et al., 2006; Reubinoff et al., 2000; Thomson
et al., 1998; Yu and Thomson, 2008). Technically, however,
hESC/iPSCs are difficult to culture, displaying slow growth
and poor survival, especially upon cellular detachment and
dissociation. Thus, hESCs were originally cultured in clus-
ters on supporting feeder layers (Reubinoff et al., 2000).
Feeder-free culture is possible if hESC/iPSCs are grown in
Matrigel with chemically defined medium (Ludwig et al.,
2006). In addition, methods such as culturing hESC/iPSCs
in suspension (Steiner et al., 2010), with microcarriers
(Bardy et al., 2013), or on synthetic polymers (Villa-Diaz
et al., 2013) have been introduced. These new techniques,
however, are expensive, have limited scalability, and may
have high batch-to-batch variability. Y-27632, a ROCK in-
hibitor, is used to prevent cell apoptosis after cell dissocia-
tion and to promote cell viability after plating (Ohgushi
et al., 2010; Watanabe et al., 2007), but the benefit of this
chemical is limited to a brief period after cell dissociation
and its continued effects on cell survival and proliferation
are questionable (Couture, 2010). Thus, culture methods
that are low cost, robust, scalable, easy to use, and consis-
tent remain to be further developed to allow widespread
applications of hESC/iPSCs in basic research and clinical.
Human neural stem cells (hNSCs) were derived by
in vitro differentiation of hESC/iPSCs. The hESC/iPSC-
derived NSCs (hES/iPS-NSCs) homogeneously expressedStem Cnestin, a representative NSC-specific marker (Park et al.,
2005). These nestin+ hNSCs can be expanded with basic
fibroblast growth factor (bFGF) and differentiate toward
neuronal cells upon withdrawal of bFGF and in the pres-
ence of combinatory neurotrophic factors (Park et al.,
2005; Perrier et al., 2004). In an experiment involving a
doxycycline-inducible expression system, we accidentally
observed that doxycycline (1 mg/ml) itself promoted
hNSC survival; the cell survival effect was not associated
with exogene expression. These observations prompted
us to scrutinize the doxycycline action further in undiffer-
entiated hESC/iPSC cultures.
We herein show that simple supplementation with
doxycycline greatly improves both hESC/iPSC viability
and self-renewal. In practice, doxycycline dramatically en-
hances hESC/iPSC expandability, and the effects continue
for long time periods. The effects of doxycycline are medi-
ated by direct activation of the PI3K-AKT intracellular
pathway, which has recently been reported as the most
crucial signal for hESC/iPSC self-renewal (Bendall et al.,
2007; Singh et al., 2012).RESULTS
We recently showed that hNSCs are extremely sensitive
to insulin, an indispensable culture supplement, and
thus survival of these cells is ensured only within a narrow
range of low insulin concentrations (Rhee et al., 2013).
In addition, survival of hNSC derived from hESC/
iPSCs is greatly dependent on the cultured cell density.ell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The Authors 353
Figure 1. Effects of Doxycycline Supplementation on Cultures of hNSCs and Neurons Derived from hESC/iPSCs
(A and B) Doxycycline prevents apoptotic cell death induced by high concentrations of insulin (A) or low cell density (B) in hNSC cultures.
H9 hESC-derived NSCs plated at 1.4 3 105 /cm2 (A) or 2 3 104 /cm2 (B) were cultured with or without doxycycline supplementation
(1 mg/ml). Apoptotic cell deaths were estimated by viable cell counts (upper) and cells positive for activated (cleaved) caspase 3 (lower).
*Significantly different from untreated control at p < 0.01, Student’s t test, n = 3 replicates in duplicate. Representative phase-contrast and
cleaved caspase-3-stained images in the cultures with the high insulin concentration (5 uM) are shown in the left panels. Scale bars, 50 mm.
(C) The effect of doxycycline on neuron survival. Subtypes of neurons were derived by differentiation of H9 hES-NSCs for 9 days. The
neuronal cultures were maintained with or without doxycycline supplementation for 5 days. n = 4 technical replicates/experiment, n = 2
experiments. On the last day of culture, immunostaining was performed to identify dopaminergic (tyrosine hydroxylase, TH), serotonergic
(serotonin), and GABAergic (GABA) neurons. Scale bars, 50 mm.
(D–H) Doxycycline supplementation prevents early senescence and apoptotic cell death in viral hiPS-derived NSCs during cell passaging.
NSCs derived from the retroviral (Rv-hiPS 02-3, E), lentiviral hiPSC lines (IMR 90-1, F), and H9 hESCs (control, D) were expanded by
passaging every 7 days in the absence or presence of doxycycline supplementation. The cell growth curves shown in (D)–(F) were generated
by counting total viable cell numbers from n = 3 technical replicates of each doxycycline-treated and untreated culture on the last day of
every passage. (G) Statistical analysis on the cell number increases from the three cell lines tested was carried out (n = 3 biological
replicates). *Significant increases of viable cell numbers in the doxycycline-supplemented cultures at p < 0.001, Student’s t test. (H)
Representative b-galactosidase (upper, cellular senescence) and activated caspase-3 (lower, apoptosis)-stained cells in the Retro-2-hiPS-
NSC cultures untreated (left) and treated with doxycycline (right) on the last day of passage 4. Scale bars, 50 mm. All data shown in this
study are expressed as mean ± SEM.
See also Figure S1.
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Doxycycline as a Supplement for hESC/hiPSC CultureDoxycycline supplementation (1 mg/ml) strikingly pre-
vented apoptotic cell death induced by high insulin con-
centration or low cell density in H9 hESC-derived NSC
cultures, as revealed by estimations of total numbers of
viable cells and cells positive for activated caspase-3 (Fig-
ures 1A and 1B) and Annexin V/propidium iodide (PI)
(data not shown).We then tested the effects of doxycycline354 Stem Cell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The Auton differentiated neurons. Dopamine, serotonin, and
gamma-aminobutyric acid (GABA)-secreting neurons are
derived by terminal differentiation of hES/iPS-NSCs. The
neurons underwent apoptosis if the neurotrophic factors
supplemented were withdrawn, which substantially
reduced the numbers of each neuronal subtype. Doxycy-
cline largely prevented such apoptosis and neuronal losshors
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Doxycycline as a Supplement for hESC/hiPSC Culture(Figure 1C). Doxycycline from different sources (com-
panies) showed similar effects on hNSC survival (Figures
S1A and S1B available online). The doxycycline analogs
tetracycline and minocycline also promoted cell survival,
but other antibacterial agents did not, indicating that
doxycycline-mediated cell survival is not associated with
its antibiotic effect.
NSCs derived from hESCs (hES-NSCs) are highly
expandable for prolonged periods of proliferation through
multiple cell passages (Hong et al., 2008; Ko et al., 2007).
Doxycycline increased cell yields attained during expan-
sion of H9 hES-NSCs through eight passages (Figure 1D).
Neuronal differentiation of the multipassaged hNSCs
treated with doxycycline was not altered (data not shown).
In contrast to hES-NSCs, we have recently shown that
NSCs derived from hiPSCs established using viral vector-
mediated gene delivery (viral hiPSCs) exhibited early
senescence and apoptotic cell death during passaging
(Rhee et al., 2011). Thus, cultures of NSCs derived from
viral hiPSCs (viral hiPS-NSCs) were barely maintained for
two to four cell passages; no definite cell expansion took
place and at the end of this period, none were viable
(Rhee et al., 2011) (Figures 1E and 1F). Hemangioblasts
derived from viral hiPSCs versus hESCs likewise exhibited
differences in expansion potential and senescence (Feng
et al., 2010). Doxycycline supplementation strikingly pre-
vented senescence of retroviral- and lentiviral-based hiPS-
NSCs during passaging (Figure 1H; data not shown).
Indeed, doxycycline addition allowed the viral hiPS-NSC
cultures to be maintained for at least seven cell passages
and to undergo discrete cell number increases (Figures 1E
and 1F). These findings strongly indicate that doxycycline
supplementation circumvents the limitation of viral hiPS-
NSCs as a stable cell source.
Based on doxycycline-mediated effects on cell survival
in neural lineages at different developmental stages, we
postulated that the effects of doxycycline and its analogs
would extend to cells at earlier developmental stages,
such as pluripotent stem cells. Culturing human pluripo-
tent hESC/hiPSCs is technically difficult, with problems
in maintaining self-renewal and pluripotency for long
periods of culture and massive cell death occurring, partic-
ularly after cell dissociation. To examine the effect of doxy-
cycline on human pluripotent stem cell survival, hESC
(H9) clusters were dissociated into one to five cells and
plated on Matrigel in mTeSR1 medium in the presence or
absence of doxycycline (1 mg/ml). Doxycycline supplemen-
tation strikingly increased formation of colonies that were
positive for alkaline phosphatase (AP), an undifferentiated
hES/iPSC marker, 5 days after plating (22.5 ± 13.5 versus
99.3 ± 11.2 colonies/cm2 without versus with doxycycline,
respectively). Enhanced AP+ colony formation in the
presence of doxycycline was also apparent in all otherStem ChESC (HSF6) and hiPSC lines tested (Rv-hiPS 01-1 and
Rv-hiPS 02-3 (retroviral-hiPSCs); IMR90-1 and IMR90-4
(lentiviral-hiPSC); piPS-#1 and piPS-#2 (protein based-
hiPSC)) (Figure 2A). The doxycycline effect was further
confirmed by counting colonies expressing the other
pluripotent cell markers NANOG and TRA-1-60 in cultures
of the commonly used hESC lines H1, H7, H9, HUES6,
and HSF6 (Figure 2B; data not shown) and in different
culture conditions (Figure 2C). In gene expression arrays,
expression of 35 of 39 apoptosis-related genes was lower
in doxycycline-treated versus untreated hESCs, whereas
the opposite pattern occurred for antiapoptotic gene ex-
pression (Figure 2D).
Y-27632, a selective Rho-associated kinase (ROCK)
inhibitor, is known to facilitate hESC/hiPSC culture growth
by diminishing dissociation-induced apoptosis (Ohgushi
et al., 2010; Watanabe et al., 2007). We therefore compared
doxycycline- and Y-27632-mediated hESC survival by the
colony-forming assay using H9 cells in Matrigel coating-
mTeSR1 medium culture. Cell numbers increased more
during 5 days of culture in the doxycycline-supplemented
cultures than in either the untreated or Y-27632-treated
cultures (Figure 2E). The number of colonies (colony-form-
ing efficiency) was robustly greater in the cultures treated
with doxycycline (81.9 ± 12.7 colonies/well) or Y-27632
(79.6 ± 11.7 colonies/well) than in the untreated control
(20.3 ± 6.7 colonies/well); the doxycycline and Y-27632
effects were indistinguishable (Figure 2F). However, colony
sizes (average numbers of cells assembled in a colony) in
the doxycycline-treated group (136.2 ± 8.1 cells/colony)
were significantly larger than those in the Y-27632-treated
group (103.8 ± 10.5 cells/colony) and untreated control
(80.9 ± 6.3 cells/colony) (Figure 2G). Cell colonies in Y-
27632-treated cultures differed somewhat in shape as
compared with those of the control cultures, with less
compactly arranged cells that exhibited bipolar cellular
processes (Figure 2H), probably because of altered Rho
kinase activity, which is associated with changes in cell
morphology (Harb et al., 2008) (the cell morphologies re-
turned to normal within several hours after Y-27632 with-
drawal). In contrast, cell and colony shapes in the doxycy-
cline-treated cultures were indistinguishable from those
of the untreated culture. Notably, the percent of AP+ undif-
ferentiated hESC colonies in the total number of colonies
was significantly higher in the doxycycline-treated cultures
than in the untreated control and Y-27632-treated cultures
(74.7% ± 1.6% in doxycycline-treated, 66.9% ± 1.8% in Y-
27632-treated, 64.3% ± 3.3% in untreated cultures, Fig-
ure 2I). Expression of genes encoding human transcription
factors generally appeared similar for doxycycline-treated
and untreated hESCs in gene expression arrays, but
expression levels of genes related to hESC pluripotency
were greater in the doxycycline-treated cultures (Figure 2J).ell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The Authors 355
(legend on next page)
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Doxycycline as a Supplement for hESC/hiPSC CultureThe increased pluripotency marker gene expression was
confirmed using real-time PCR (data not shown). Doxycy-
cline’s ability tomaintain an undifferentiated state was also
apparent inmouse ESCs (mESCs) that had been engineered
to contain Oct3/4 promoter-driven GFP: doxycycline treat-
ments increased the percentage of GFP+ cells (Figure S2).
Taken together, these findings indicate that doxycycline
supplementation generates greater yields of undifferenti-
ated hESCs in culture, not only by promoting cell survival
but also by maintaining self-renewal.
Becauseof their vulnerabilityafter cell dissociation,hESC/
iPSCs are commonlymaintained in clusterswithout dissoci-
ation on a feeder layer of mouse embryonic fibroblasts
(MEFs). Thus, we examined whether doxycycline supple-
mentation would confer a practical benefit: facilitating the
expansion and maintenance of undifferentiated hESC/
iPSCs in culture for long periodswithmultiple cell passages.
The doxycycline-mediated hESC survival and self-renewal
shown in colony-forming assays (Figure 2) were further
confirmed using fluorescence-activated cell sorting (FACS)
onhESC/iPSCs cultured in clusters (Figures3Aand3B).Cells
on apoptosis (Annexin V+/PI+) were greatly reduced by
doxycycline treatment (Figure 3A), along with decrease of
dead cell populations (Figure 3B). In addition, significantly
more cell populations in hESC (H9) andhiPSC (Lenti-1) cul-
tureswereaccumulated inSphasebydoxycycline treatment
(Figure 3B).WhenH9hESCswere subcultured in clusters on
MEF feeders, increases of >5-fold and >120-fold in cell num-Figure 2. Doxycycline Supplementation Enhances Cell Survival an
(A–C) Colony-forming efficiency. hESC/iPSCs were dissociated into on
Matrigel with mTeSR1 medium in the absence or presence of doxycycli
hESC/iPSC markers AP (A), NANOG (B), or TRA-1-60 (C) were counted. I
*p < 0.05(B), Student’s two-tailed t test. n = 58 (A and B) pairs of
Numbers of experiments for each assay are indicated on the graphs. Da
collected at different times and presented in one graph for ease. The ef
in the different culture conditions indicated using the H9 hESC line (
(D) Expression arrays for anti-/proapoptotic genes altered by doxycycl
doxycycline and expression levels of anti-/proapoptotic genes were
demonstrating a tendency of increased antiapoptotic (red dots) and de
cultures (technical triplicates). Each dot is mean value of the trip
expression threshold. The gene names significantly up- or downregul
treatment are shown in the graph.
(E–I) Comparison of the effects of doxycycline and Y-27632 on hESC su
density (500 cells/well, 96-well plate) and cultured on Matrigel in mTe
27632 (10 mM) for 5 days. Cell growth for 5 days is shown in (E). Num
0.001 compared to the control group, #p < 0.05 compared to Y-27632
experiments in triplicate. (H) Phase-contrast images of representative
cultures. Insets, high-powered images of the indicated cells. Scale bars
the control group, #p < 0.05 compared to Y-27632-treated group, n =
(J) Expression levels of genes encoding human stem cell transcription
expression levels in the untreated culture (technical triplicates). In t
expression threshold. Genes whose expression is associated with plur
See also Figure S2.
Stem Cber were attained over 56 days (8 passages) and 140 days of
culture (20 passages), respectively, by simply adding doxy-
cycline (Figures 3C and 3D), as compared with untreated
cells, without altering the normal karyotype (Figure 3E).
Immunocytochemical (Figure 3F) and FACS (Figure 3G)
analyses showed that, in the multipassaged cultures with
doxycycline supplementation, most cells expressed undif-
ferentiated hESC markers. In addition, pluripotent poten-
tials of thehESCsmaintainedwithdoxycycline supplemen-
tation were confirmed by in vitro differentiation into three
germ layers (Figures S3A and S3B) and in vivo teratoma for-
mation (Figure S3C).
Y-27632 has been reported to permit survival of
dissociated hESCs by inhibiting actomyosin hyperactiva-
tion, which is triggered by the loss of E-cadherin (CDH1)-
dependent intercellular contact (Ohgushi et al., 2010).
In control cultures, loss of E-cadherin was obvious after
cell dissociation and followed by increased levels of
phosphorylated myosin light chain (pMLC), a marker for
actomyosin hyperactivation, within 30 min after hESC
dissociation (Figure 4A). As reported, pretreatment with
Y-27632 substantially prevented the loss of E-cadherin
and actomyosin hyperactivation. In contrast, the cell
dissociation-induced changes were not prevented by
doxycycline pretreatment (Figures 4A and 4B). Conse-
quently, atypical blebbing, a characteristic feature of hyper-
activated actomyosin, occurred in doxycycline-pretreated
cultures (Figure 4C), as it does in untreated hESCs afterd Self-Renewal of Undifferentiated hESC/iPSCs in Culture
e to five cells, and plated at 4 3 104 cells/6 cm dish in feeder-free
ne (1 mg/ml). After 5 days, colonies expressing the undifferentiated
nformation for the cell lines used is shown in Table S1. *p < 0.01(A),
doxycycline-treated and untreated culture dishes for each cell line.
ta within pairs were collected at the same time, but across pairs were
fect of doxycycline on TRA-1-60+ colony formation was also assessed
C). *p < 0.01, n = 5 experiments for each group.
ine treatment. H9 hESCs were cultured in the absence or presence of
estimated using RT2 PCR Profiler Array. Shown is a ‘‘volcano plot’’
creased proapoptotic (blue dots) transcripts in doxycycline-treated
licates. Vertical pink lines indicate the 1.5-fold change in gene
ated by >1.5-fold at p < 0.05 (horizontal blue line) by doxycycline
rvival and proliferation. Dissociated H9 cells were plated at a low cell
SR1 without or with supplementation of doxycycline (1 mg/ml) or Y-
bers (F) and sizes (G) of the colonies formed were compared. *p <
-treated group, One-way ANOVA with Tukey post hoc analysis, n = 5
colonies from untreated, Y-27632-treated, and doxycycline-treated
, 50 mm. (I) % AP+ undifferentiated colonies. *p < 0.01 compared to
9 experiments, ANOVA.
al factors in H9 cells treated with doxycycline were compared with
he scattered plot, the pink lines indicate the 2-fold change in gene
ipotency (red dots) are listed in the graph.
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Figure 3. Practical Benefits of Doxycycline Supplementation in hESC/iPSC Cultures
The effects of doxycycline supplementation were examined in undifferentiated hESC/iPSC cultures maintained in clusters without
dissociation on MEF feeder cells.
(A and B) FACS analyses for determining the fraction of cells undergoing apoptosis (A) and the fraction that had accumulated in each cell-
cycle phase (B). Small clusters of H9 hESCs or Lenti-1 hiPSCs (10-50 cells) were plated and cultured in the presence or absence of
doxycycline (1 mg/ml) for 6 days. The hESC/iPSC clusters were mechanically harvested, dissociated using TrypLE (A) or Accutase (B), 2 hr
prior to Annexin V/PI (A) or PI (B) staining. The stained populations were analyzed using FACS. n = 2 or 3 technical replicates/experiment,
n = 2 experiments (A). n = 3 experiments (B) *p < 0.05 and **p < 0.01, paired t test. Populations of dead cells (AP, apoptotic population) in
(B) were analyzed using the result of the sub-G1 area gated with PI.
(C–G) The effects of doxycycline treatment on the growth and maintenance of undifferentiated hESCs for long-term expansion. H9 hESCs
were propagated in clusters on MEF feeders in bFGF-supplemented KSR medium with or without doxycycline with multiple passages. (C–D)
(legend continued on next page)
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Doxycycline as a Supplement for hESC/hiPSC Culturedissociation (data not shown). Interestingly, activated
(phosphorylated) AKT (pAKT) levels also decreased after
hESC dissociation. Notably, pAKT levels remained stable
if cultures were pretreated with doxycycline (Figure 4A).
To determine which intracellular signaling proteins
are responsible for the doxycycline-mediated survival
and maintenance of undifferentiated hESCs, we initially
screened the activities of 46 intracellular signaling proteins
using human phospho-kinase arrays (Proteome Profiler,
R&D Systems) (Figure 4D). Levels of phosphorylated (acti-
vated) ERK (pERK), pCREB, and b-catenin (CTNNB) were
significantly greater in hESC cultures treated with doxycy-
cline versus untreated, but the changes were slight and
not substantiated in cytometric bead arrays (CBAs), another
kinase immunoassay system (Figure S4). In contrast, activa-
tion of AKT (pAKT) in doxycycline-treated cultures was the
most prominent change in the array and was further
confirmed by western blot analyses of cells under different
conditions, such as dissociated hESCs (Figure 4A) and cells
plated in clusters (data not shown). The effect of doxycy-
cline on pAKTattracted our interest because phosphoinosi-
tide 3-kinase (PI3K)-AKT intracellular signaling, in addition
to its commonly known antiapoptotic role, has been re-
vealed as themost crucial signalingpathway for themainte-
nance of hESCpluripotency and self-renewal (Bendall et al.,
2007; Singh et al., 2012). We further observed that the
doxycycline effects on hESC survival (Figure 4E), prolifera-
tion (Figure 4F), and maintenance of an undifferentiated
state (Figure 4G) were reduced or eliminated by the PI3K
inhibitors LY29007 and wortmannin. Notably, a conven-
tional autoradiogram-based assay revealed that PI3K
enzyme activity was obviously increased in hESC cultures
supplementedwithdoxycycline (Figure4H).We further car-
ried out another type of PI3K activity/inhibitor assay, in
whichdoxycycline and its analogs, butnotother antibiotics
tested, enhanced the PI3K activity in a dose-dependent
manner (Figure 4I). Because the latter PI3Kase assay assesses
enzymatic activity in a test tube containing the enzymeand
substrate in the absence of cellular extracts or components,
the observed doxycycline actionmust occur through direct
action on the PI3K enzyme, rather than indirectly through
other cellular molecules. Mechanisms for how doxycycline
acts as a direct PI3K activator remains to be identified.Cell growth curves. The curves shown in (C) were generated by counti
eight passages for 56 days from five independent experiments. *Signifi
cell passages at p < 0.001, Student’s two-tailed t test. Doxycycline su
passages (for 140 days) from three technical replicate (n = 1 experim
accumulated total cell numbers and fold increases at passage 20 compa
passages of doxycycline-supplemented cultures. The chromosomal an
cytochemical (F) and FACS (G) analyses showing the expression of u
presence of doxycycline. Blue populations in (G) are negative contro
See also Figure S3.
Stem CDISCUSSION
This study began with the serendipitous observation
that doxycycline treatment strongly enhances hNSC and
neuron viability. Similar to our results, previous studies
have shown that doxycycline and its analog mino-
cycline are cytoprotective toward terminally differentiated
neuronal cells (Jantzie et al., 2005; Yrja¨nheikki et al., 1998);
as such, these drugs have been used to treat ischemic brain
injury (Kim and Suh, 2009). Furthermore, a recent study
has demonstrated that preconditioning rat brain-derived
NSCs with minocycline increases the viability of the
grafted NSCs after transplantation in rat stroke model
(Sakata et al., 2012). The neuroprotective effects were re-
ported to be attained by inhibition of microglial activation
(Wang et al., 2005; Yrja¨nheikki et al., 1998), other anti-in-
flammatory actions (Hu et al., 2010), or inhibition of met-
alloproteinases (Garrido-Mesa et al., 2013). Given these
mechanisms of action, doxycycline and its analogs have
also been tested and found to enhance mesenchymal
stem cell-driven cartilage repair and chondrogenesis (Lee
et al., 2013). Although these extra-antimicrobial actions
have been published for a number of years, the commonly
used doxycycline-inducible gene expression system is
often employed without regard for such activity. Our study
suggests that this activity should indeed be considered
when using this inducible expression system.
Our study extended the doxycycline-mediated cell sur-
vival effect to human pluripotent ESC/iPSCs. In addition,
we show that hESC/iPSC self-renewal is promoted by doxy-
cycline supplementation. Because microglia and inflam-
matory cells are not present in hESC/iPSC cultures and
the doxycycline effects were manifested in isolated single
cells, the effects must not be attained through doxycy-
cline’s reported extrinsic/environmental modulations.
Instead, we show that in hESC/iPSCs, doxycycline directly
activates the PI3K-AKT pathway, which has, in addition to
its involvement in general cell survival, been reported to be
the most crucial regulatory pathway for self-renewal of un-
differentiated human pluripotent stem cells (Bendall et al.,
2007; Singh et al., 2012). It is intriguing to consider how
doxycycline might activate PI3K enzyme activity. How-
ever, it is difficult to predict the underlying mechanisms,ng total viable cell numbers on the last day of every passage during
cantly different from the respective untreated controls at the same
pplementation effect on cell growth was further examined up to 20
ent) (D). The curves shown in (D) are the natural logarithm (Ln) of
red to passage 1 (inset). (E) Unaltered karyotype of H9 cells after 20
alysis was done in 20 randomly chosen nuclei. (F and G) Immuno-
ndifferentiated hESC markers in the multipassaged H9 cell in the
ls without the primary antibody reactions. Scale bars, 50 mm.
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Figure 4. Doxycycline Permits Cell Survival and Maintenance of Undifferentiated hESCs through PI3K-AKT Signal Activation.
(A–C) Cell dissociation-induced actomyosin hyperactivation is prevented by Y-27632, but not by doxycycline treatment. H9 hESCs were
incubated with doxycycline or Y-27632 or without these chemicals (control) for 1 hr prior to cell dissociation. Cells were then harvested 0,
10, and 30 min after cell dissociation and subjected to western blot analyses to detect proteins involved in cell-dissociation-induced
apoptosis (A). Shown in (B) and (C) are representative pMLC-immunostained and phase-contrast images of dissociated hESCs in the
cultures treated with Y-27632 or doxycycline. Cells pretreated with Y-27632 or doxycycline were dissociated, directly plated onto Matrigel
with mTeSR1 and cultured in the continuous presence of the chemicals. The images were captured at the indicated time after plating
(dissociation). Scale bars, 30 mm.
(D) Estimation of intracellular signals activated by doxycycline. H9 hESCs were incubated without (control) or with doxycycline (1 mg/ml)
for 30 min before harvesting and then subjected to immunoblot analyses using the human phosphokinase blot array, which is designed to
detect 46 phosphorylated intracellular proteins. The array analyses were performed in technical triplicate. Shown is a representative pair of
blots of the untreated control and doxycycline-treated cells. In the blots, spots whose intensities are greater (>1.5-fold) in the doxy-
cycline-treated group, compared to the control, are marked with dotted circles and listed with the fold increase (parentheses) in the inset.
**p < 0.001 and *p < 0.05, paired t test. Reference spots are underlined.
(legend continued on next page)
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Doxycycline as a Supplement for hESC/hiPSC Culturesuch as which structural moieties of doxycycline might be
responsible for its activator function; unlike enzyme inhib-
itors, intracellular kinase activators are uncommon and
structure-based predictions for activator mechanisms are
not feasible. Thus, the mechanism for doxycycline’s effect
on PI3K activity remains to be identified in future studies.
We show that hESC dissociation not only leads to acto-
myosin hyperactivation, but also reduces Akt signaling,
events that are prevented by Y-27632 and doxycycline,
respectively. Thus, these chemicals additively or synergisti-
cally prevented cell apoptosis for 1 day after cells were
plated following cell detachment and dissociation (data
not shown). However, unlike doxycycline, the long-term
effects of Y-27632 are unclear and Y-27632 is associated
with aneuploidy (Couture, 2010; Riento and Ridley,
2003) and cell morphology changes (Figure 2H). Therefore,
the best hESC/iPSC growth was attained by combined
treatment of doxycycline and Y-27632 for 1 day after
plating, followed by doxycycline supplementation alone
for the remaining culture period (data not shown).
In summary, our findings demonstrate that doxycycline
promotes hESC/iPSC survival and self-renewal via PI3K-
AKT signal activation. These effects are also apparent in
NSCs and differentiated neurons; AKT activation was also
observed in the cells of neural lineages (data not shown).
Given that AKT activation is a common cell survival signal
in many kinds of cells, these findings suggest that doxycy-
cline can be used as a cell culture supplement in wide range
of cellular types. Doxycycline and its analog minocycline
are already being used in clinics, suggesting that doxycy-
cline supplementation would be acceptable in the stem
cell cultures used for clinical applications.EXPERIMENTAL PROCEDURES
Cell Culture
hESCs and hiPSCs were grown based on hESC research guidelines
approved by the institutional review board (IRB) at Hanyang Uni-
versity (Seoul, Korea) under HYE-08-02. hiPSCs and hESCs used in
this study are listed in Table S1. For expansion andmaintenance of(E–G) Doxycycline-induced effects on the number (E), size (F), and per
PI3K-AKT signaling. The colony-forming assays were performed by c
(DMSO, ) or doxycycline (1 mg/ml) with or without the PI3K-AKT b
blocker PD98059 (10 mM). Significantly different from the control cult
doxycycline alone at #p < 0.05, n = 3 experiments per group, one-wa
(H and I) PI3K enzyme activity enhanced by doxycycline. (H) Conve
periments). As a positive control for the assay, PI3K activities were det
MDA-MB-231) with or without a reported PI3K inhibitor (eckol) (Hyu
activity was further assessed using a PI3 kinase activity/inhibitor a
antibiotics or known PI3K inhibitors (controls). All error bars represen
tetracycline (Tet); minocycline (Mino); kanamycin (Kan); chloramphe
enzyme activities after subtracting the activity without the inhibitor
See also Figure S4.
Stem Cundifferentiated hESC/iPSCs, cells were cultured on a feeder layer
of MEF cells (CF1 mouse, Charles River Kingston) in KSR medium
(knockout serum replacements; Invitrogen) supplemented with
4 ng/ml basic fibroblast growth factor (bFGF, R&D Systems). The
cultures were passaged every week in clusters by mechanically
splitting (or by mild pipetting with collagenase IV [0.1 mg/ml;
STEMCELL Technologies]) and transferring hESC/iPSC clusters
onto freshly prepared MEF feeder layers. For colony-forming
assays, hESC/iPSC clusters were dissociated into one to five cells us-
ing collagenase IV (0.1 mg/ml; STEMCELL Technologies) or Accu-
tase (STEMCELLTechnologies), plated at 43 104 cells/6 cm culture
dish (or 500 cells/well, 96-well plate) on Matrigel (BD Biosciences)
with mTeSR1 (STEMCELL Technologies), without feeder layers.
The colony-forming assay was also performed in different media
conditions such as Pluristem (Millipore) with Matrigel, DMEM/
F12-, or DMEM-based KSR medium on MEF feeder layers. KSR me-
dium supplemented with bFGF andmTeSR1mediumwas changed
every day without special mention. hNSC cultures were derived by
in vitro differentiation of hESCs and hiPSCs as previously
described (Ko et al., 2007; Rhee et al., 2011). The hNSCs were
expanded with bFGF (20 ng/ml) in ITSA media (Park et al., 2005;
Rhee et al., 2011) and subcultured every week for long-term expan-
sion. Terminal differentiation of the hNSCs was induced in the
absence of bFGF but in the presence of brain-derived neurotrophic
factor (20 ng/ml; R&DSystems), glial cell line derivedneurotrophic
factor (20 ng/ml; R&D Systems), or dibutyryl cAMP (0.5 mmol/l;
Sigma). The following chemicals were used: doxycycline (Sigma;
Calbiochem; Tocris), minocycline (Sigma), tetracycline (Sigma),
kanamycin (Sigma), blasticidin (Invitrogen), chloramphenicol
(Sigma), Y-27632 (Calbiochem), LY 294002 (Calbiochem), wort-
mannin (Millipore), and PD 98059 (Calbiochem).
Immunostaining
Cultured cells were fixed with 4% paraformaldehyde in PBS and
incubated overnight at 4Cwith primary antibodies listed in Table
S2. Appropriate fluorescence-tagged secondary antibodies (Jackson
ImmunoResearch Laboratories) were used for visualization.
Stained samples were mounted in VECTASHIELD with DAPI
mounting solution (Vector Laboratories).
Cell-Cycle and Death Analyses
Cell viability was determined by the MTT assay as previously
described (Twentyman and Luscombe, 1987). Apoptotic cell deathcentage (G) of AP+ colonies are abolished by the blockers specific for
ulturing dissociated H9 cells for 5 days in the presence of vehicle
lockers LY29002 (20 mM) or wortmannin (100 mM) or the RAF-ERK
ures treated with vehicle at *p < 0.001 and the cultures treated with
y ANOVA with Tukey post hoc analysis.
ntional autoradiograph-based PI3K activity assay (duplicated ex-
ermined, in parallel, in a control cell line (human breast cancer cells
n et al., 2011) (left panel). (I) The effect of doxycycline on PI3K
ssay kit. The assays were also carried out in the presence of other
t SEM of at least five independent experiments. Doxycycline (Dox);
nicol (Chlor); blastcidine (Blas). The graph depicts calculated PI3K
/activator. Inset, doxycycline dose-dependent PI3K activity curve.
ell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The Authors 361
Stem Cell Reports
Doxycycline as a Supplement for hESC/hiPSC Culturewas assessed with the percentage of cells positive for the apoptotic
cell-specificmarkers cleaved Caspase-3 and Annexin V/PI by direct
counting on microscope. Annexin V/PI-stained cells were further
counted by using FACS (CantoII, BD Biosciences). FACS analysis
was also applied for determining cell populations accumulated
on each cell-cycle phase using FlowJo xV.0.7 software (Tree Star).
Cell senescencewas determined by the Senescence b-Galactosidase
StainingKit (Cell Signaling Technology) according to themanufac-
turer’s instructions.
Alkaline Phosphatase Activity Analysis
Alkaline Phosphatase Substrate kit I (Vector) was used to analyze
alkaline phosphatase activity within clusters according to the
manufacturer’s instructions.
Evaluation of Pluripotency
In vitro differentiation of the hESCs into the three germ layers was
induced by withdrawing bFGF from feeder-free cultures for
2 weeks, after which cells were immunostained formarkers specific
for endoderm (FOXA2, a-Fetoprotein [AFP]), mesoderm (smooth
muscle actin [SMA], BRACHYURY), and ectoderm (TUJ1,GFAP).
In vivo teratoma formation was induced by injecting 1 3 106 H9
hESCs (cultured for 56 days with eight passages in the presence
of doxycycline) under the gonad of 6-week-old NOD/SCID mice.
Eight weeks later, the resulting tumors were removed and
embedded in paraffin. Sections were stained with hematoxylin
and eosin (H&E).
Karyotyping
Karyotypingwas carried out onhESCs (H9)maintained in the pres-
ence of doxycycline (1 mg/ml) by standard G banding at the NEO-
DIN Medical Institute (Seoul, Korea).
Quantitative PCR Analyses
Total RNA preparation and cDNA synthesis were performed as
previously described (Brederlau et al., 2006). High-throughput
gene expression profiling was done for human stem cell transcrip-
tional factors (cat. 330231 PAHS-501ZA) and cell apoptosis-related
proteins (cat. 330231 PAHS-012ZA) using RT2 Profiler PCR Array
(QIAGEN). The results were further confirmed using conventional
real-time PCR analysis (Park et al., 2005).
Determination of Intracellular Signal Activation
Intracellular signals activated by doxycycline treatment were
screened using Human Phospho-Kinase Array (Proteome Profiler
Array, R&D Systems) and CBAmultiplexed bead-based immunoas-
says (560005, 560010, 560012, 560013, 560015, 560059, 560065,
560093, 560150, 560792, BD) according to the manufacturers’
protocols. Western blot analyses were performed as previously
described (Chang et al., 2007) to confirm the results from the
screens or to determine the levels of proteins, such as E-cadherin
and pMLC, associated with actomyosin hyperactivation.
PI3 Kinase Activity Assay
A conventional autoradiograph-based PI3K activity assay was
carried out as previously described (Hyun et al., 2011). Briefly,362 Stem Cell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The AutPI3K was immunoprecipitated with an anti-PI3K antibody (anti-
p85) from total cell extracts from H9 hESCs that had been
cultured in the presence or absence of doxycycline. Enzymatic
reactions were initiated by adding [g-32P]ATP and L-a-phosphati-
dylinositol (substrate) to the precipitates, and the radiolabeled
product from the reaction was detected using autoradiography.
The effects of doxycycline on PI3K activity were further deter-
mined using a commercially available PI3 kinase activity/
inhibitor assay kit (Millipore), in which recombinant class I
PI3K enzyme proteins react the substrate PIP2 in the absence
of cell extracts. PI3K activator/inhibitor activities were calcu-
lated according to the manufacturer’s instructions with some
modifications.Cell Counting and Statistical Analysis
Immunoreactive cells (colonies) were counted in a whole area
(96-well plate) or in uniform randomly chosen areas using an
eyepiece grid at 2003 (24-well plate) or culture dishes with grid
(6 cm) at 403 or 1003. Statistical comparisons between two groups
were made by Student’s two-tailed t test or two-tailed paired t test.
One-way ANOVA with Tukey post hoc analysis (SPSS) was applied
whenmore than two groups were compared. Data are expressed as
mean ± SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and two tables
and can be found with this article online at http://dx.doi.org/10.
1016/j.stemcr.2014.06.013.AUTHOR CONTRIBUTIONS
M.-Y.C. and Y.-H.R. designed and performed experiments,
analyzed data, and helped write the manuscript. S.-H.Y. carried
out FACS and Phospho-Kinase Array analyses. S.-J.L. and R.-K.K.
performed the PI3 kinase activity assays. H.K. performed the ex-
periments to test doxycycline effects in mouse ESCs and teratoma
formation assay. C.-H.P. gave technical support and conceptual
advice. S.-H.L. funded the project, provided conceptual overview,
designed and interpreted experimental results, and wrote the
manuscript.ACKNOWLEDGMENTS
This work was supported by grants from the Bio & Medical
Technology Development Program (2010-0020232), the Medical
Research Center (2008-0062190), and the basic science research
program (2012R1A1-A3010261), funded by the National Research
Foundation of Korea (NRF) of the Ministry of Education, Science
and Technology (MEST), Republic of Korea and the research fund
ofHanyang university (HY-2014).We appreciateDr. SureshRamak-
rishna and Myungjae Song for their technical supports.
Received: October 23, 2013
Revised: June 24, 2014
Accepted: June 25, 2014
Published: July 24, 2014hors
Stem Cell Reports
Doxycycline as a Supplement for hESC/hiPSC CultureREFERENCES
Bardy, J., Chen, A.K., Lim, Y.M.,Wu, S.,Wei, S.,Weiping, H., Chan,
K., Reuveny, S., and Oh, S.K. (2013). Microcarrier suspension cul-
tures for high-density expansion and differentiation of human
pluripotent stem cells to neural progenitor cells. Tissue Eng. Part
C Methods 19, 166–180.
Bendall, S.C., Stewart, M.H., Menendez, P., George, D., Vijayaraga-
van, K., Werbowetski-Ogilvie, T., Ramos-Mejia, V., Rouleau, A.,
Yang, J., Bosse´, M., et al. (2007). IGF and FGF cooperatively estab-
lish the regulatory stem cell niche of pluripotent human cells
in vitro. Nature 448, 1015–1021.
Brederlau, A., Correia, A.S., Anisimov, S.V., Elmi, M., Paul, G.,
Roybon, L., Morizane, A., Bergquist, F., Riebe, I., Nannmark, U.,
et al. (2006). Transplantation of human embryonic stem cell-
derived cells to a rat model of Parkinson’s disease: effect of
in vitro differentiation on graft survival and teratoma formation.
Stem Cells 24, 1433–1440.
Chang, M.Y., Sun, W., Ochiai, W., Nakashima, K., Kim, S.Y., Park,
C.H., Kang, J.S., Shim, J.W., Jo, A.Y., Kang, C.S., et al. (2007). Bcl-
XL/Bax proteins direct the fate of embryonic cortical precursor
cells. Mol. Cell. Biol. 27, 4293–4305.
Couture, L.A. (2010). Scalable pluripotent stem cell culture. Nat.
Biotechnol. 28, 562–563.
Feng, Q., Lu, S.J., Klimanskaya, I., Gomes, I., Kim, D., Chung, Y.,
Honig, G.R., Kim, K.S., and Lanza, R. (2010). Hemangioblastic
derivatives from human induced pluripotent stem cells exhibit
limited expansion and early senescence. Stem Cells 28, 704–712.
Garrido-Mesa, N., Zarzuelo, A., and Ga´lvez, J. (2013). Minocycline:
far beyond an antibiotic. Br. J. Pharmacol. 169, 337–352.
Harb, N., Archer, T.K., and Sato, N. (2008). The Rho-Rock-Myosin
signaling axis determines cell-cell integrity of self-renewing plurip-
otent stem cells. PLoS ONE 3, e3001.
Hong, S., Kang, U.J., Isacson, O., and Kim, K.S. (2008). Neural pre-
cursors derived from human embryonic stem cells maintain long-
termproliferationwithout losing the potential to differentiate into
all three neural lineages, including dopaminergic neurons.
J. Neurochem. 104, 316–324.
Hu, X., Zhou, X., He, B., Xu, C.,Wu, L., Cui, B.,Wen, H., Lu, Z., and
Jiang, H. (2010). Minocycline protects against myocardial
ischemia and reperfusion injury by inhibiting highmobility group
box 1 protein in rats. Eur. J. Pharmacol. 638, 84–89.
Hyun, K.H., Yoon, C.H., Kim, R.K., Lim, E.J., An, S., Park, M.J.,
Hyun, J.W., Suh, Y., Kim,M.J., and Lee, S.J. (2011). Eckol suppresses
maintenance of stemness and malignancies in glioma stem-like
cells. Toxicol. Appl. Pharmacol. 254, 32–40.
Jantzie, L.L., Cheung, P.Y., and Todd, K.G. (2005). Doxycycline
reduces cleaved caspase-3 and microglial activation in an animal
model of neonatal hypoxia-ischemia. J. Cereb. Blood Flow Metab.
25, 314–324.
Kim, H.S., and Suh, Y.H. (2009). Minocycline and neurodegenera-
tive diseases. Behav. Brain Res. 196, 168–179.
Ko, J.Y., Park, C.H., Koh,H.C., Cho, Y.H., Kyhm, J.H., Kim, Y.S., Lee,
I., Lee, Y.S., and Lee, S.H. (2007). Human embryonic stem cell-
derived neural precursors as a continuous, stable, and on-demandStem Csource for human dopamine neurons. J. Neurochem. 103, 1417–
1429.
Lee, H.H., O’Malley, M.J., Friel, N.A., and Chu, C.R. (2013). Effects
of doxycycline on mesenchymal stem cell chondrogenesis and
cartilage repair. Osteoarthritis and cartilage / OARS. Osteoarthritis
Research Society 21, 385–393.
Ludwig, T.E., Levenstein, M.E., Jones, J.M., Berggren, W.T.,
Mitchen, E.R., Frane, J.L., Crandall, L.J., Daigh, C.A., Conard,
K.R., Piekarczyk, M.S., et al. (2006). Derivation of human embry-
onic stem cells in defined conditions. Nat. Biotechnol. 24,
185–187.
Ohgushi, M., Matsumura, M., Eiraku, M., Murakami, K., Aramaki,
T., Nishiyama, A., Muguruma, K., Nakano, T., Suga, H., Ueno, M.,
et al. (2010). Molecular pathway and cell state responsible for
dissociation-induced apoptosis in human pluripotent stem cells.
Cell Stem Cell 7, 225–239.
Park, C.H., Minn, Y.K., Lee, J.Y., Choi, D.H., Chang, M.Y., Shim,
J.W., Ko, J.Y., Koh, H.C., Kang, M.J., Kang, J.S., et al. (2005).
In vitro and in vivo analyses of human embryonic stem cell-
derived dopamine neurons. J. Neurochem. 92, 1265–1276.
Perrier, A.L., Tabar, V., Barberi, T., Rubio, M.E., Bruses, J., Topf, N.,
Harrison, N.L., and Studer, L. (2004). Derivation of midbrain
dopamine neurons from human embryonic stem cells. Proc.
Natl. Acad. Sci. USA 101, 12543–12548.
Reubinoff, B.E., Pera,M.F., Fong, C.Y., Trounson, A., and Bongso, A.
(2000). Embryonic stem cell lines fromhumanblastocysts: somatic
differentiation in vitro. Nat. Biotechnol. 18, 399–404.
Rhee, Y.H., Ko, J.Y., Chang,M.Y., Yi, S.H., Kim,D., Kim, C.H., Shim,
J.W., Jo, A.Y., Kim, B.W., Lee, H., et al. (2011). Protein-basedhuman
iPS cells efficiently generate functional dopamine neurons and can
treat a rat model of Parkinson disease. J. Clin. Invest. 121, 2326–
2335.
Rhee, Y.H., Choi, M., Lee, H.S., Park, C.H., Kim, S.M., Yi, S.H., Oh,
S.M., Cha, H.J., Chang, M.Y., and Lee, S.H. (2013). Insulin concen-
tration is critical in culturing human neural stem cells and neu-
rons. Cell Death Dis. 4, e766.
Riento, K., and Ridley, A.J. (2003). Rocks: multifunctional kinases
in cell behaviour. Nat. Rev. Mol. Cell Biol. 4, 446–456.
Sakata, H., Niizuma, K., Yoshioka, H., Kim, G.S., Jung, J.E., Katsu,
M., Narasimhan, P., Maier, C.M., Nishiyama, Y., and Chan, P.H.
(2012). Minocycline-preconditioned neural stem cells enhance
neuroprotection after ischemic stroke in rats. J. Neurosci. 32,
3462–3473.
Singh, A.M., Reynolds, D., Cliff, T., Ohtsuka, S., Mattheyses, A.L.,
Sun, Y., Menendez, L., Kulik, M., and Dalton, S. (2012). Signaling
network crosstalk in human pluripotent cells: a Smad2/3-regulated
switch that controls the balance between self-renewal and differ-
entiation. Cell Stem Cell 10, 312–326.
Steiner, D., Khaner, H., Cohen, M., Even-Ram, S., Gil, Y., Itsykson,
P., Turetsky, T., Idelson, M., Aizenman, E., Ram, R., et al. (2010).
Derivation, propagation and controlled differentiation of
human embryonic stem cells in suspension. Nat. Biotechnol.
28, 361–364.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A.,
Swiergiel, J.J., Marshall, V.S., and Jones, J.M. (1998). Embryonicell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The Authors 363
Stem Cell Reports
Doxycycline as a Supplement for hESC/hiPSC Culturestem cell lines derived fromhumanblastocysts. Science 282, 1145–
1147.
Twentyman, P.R., and Luscombe, M. (1987). A study of some vari-
ables in a tetrazolium dye (MTT) based assay for cell growth and
chemosensitivity. Br. J. Cancer 56, 279–285.
Villa-Diaz, L.G., Ross, A.M., Lahann, J., and Krebsbach, P.H.
(2013). Concise review: The evolution of human pluripotent
stem cell culture: from feeder cells to synthetic coatings. Stem
Cells 31, 1–7.
Wang, A.L., Yu, A.C., Lau, L.T., Lee, C., Wu, M., Zhu, X., and Tso,
M.O. (2005). Minocycline inhibits LPS-induced retinal microglia
activation. Neurochem. Int. 47, 152–158.364 Stem Cell Reports j Vol. 3 j 353–364 j August 12, 2014 j ª2014 The AutWatanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura,
M., Wataya, T., Takahashi, J.B., Nishikawa, S., Nishikawa, S.,
Muguruma, K., and Sasai, Y. (2007). A ROCK inhibitor permits
survival of dissociated human embryonic stem cells. Nat. Bio-
technol. 25, 681–686.
Yrja¨nheikki, J., Keina¨nen, R., Pellikka, M., Ho¨kfelt, T., and Koisti-
naho, J. (1998). Tetracyclines inhibit microglial activation and
are neuroprotective in global brain ischemia. Proc. Natl. Acad.
Sci. USA 95, 15769–15774.
Yu, J., and Thomson, J.A. (2008). Pluripotent stem cell lines. Genes
Dev. 22, 1987–1997.hors
